Forecasting the Oxycodone Market: By 2023 to 2033 Outlook

 

The global oxycodone market is on the brink of a significant upsurge, with Future Market Insight's latest projections pointing towards an impressive valuation of US$ 8.92 billion by 2033. This forecast highlights a remarkable Compound Annual Growth Rate (CAGR) of 5.7%, showcasing substantial progress from the expected value of US$ 5.11 billion in 2023.

In light of these promising statistics, FMI is excited to announce its anticipation of exponential growth within the oxycodone market. As a leading player in the pharmaceutical landscape, FMI is poised to capitalize on the industry's burgeoning opportunities and contribute to its upward trajectory.

The pharmaceutical sector is undergoing notable transformations, and the oxycodone market is positioned as a major beneficiary of these shifts. Future Market Insight's forecast underscores the industry's potential to emerge as a significant player on the global stage, and FMI is committed to driving innovation and meeting the evolving needs of patients worldwide.

Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-7638

Senior citizens are becoming increasingly prevalent globally, which is driving market growth. This population is more prone to getting cancer. Between 2015 and 2050, there will be a projected 12% to 22% increase in the proportion of persons 60 and older.

Global healthcare spending has significantly increased during the last 20 years. Spending on opioid drug research has also significantly grown. Additionally, there has been a discernible rise in clinical trials specifically involving oxycodone. These promising trends are expected to persist throughout the life of the projection.

The cancer incidence is the proportion of people who have not yet received a cancer diagnosis. It takes into account both the risk that cancer will manifest and the typical amount of time that people live after being diagnosed. Oxycodone, which is often used to treat cancer, is projected to have a significant impact on growth.

Palliative care, which focuses on improving patient quality of life, is provided to patients with life-threatening illnesses. Oxycodone is necessary for patients undergoing palliative care to adequately control pain. For those who have advanced cancer or other serious illnesses, this is particularly true. As palliative care is given increasing attention by healthcare organisations, there is a rising need for oxycodone.

One of the primary factors anticipated to impede market growth is the rising personal apprehension regarding the side effects linked to cancer medications. Other restraining factors include

  • limited awareness of these drugs among individuals in low and middle-income countries
  • the absence of reimbursement policies for cancer treatment in certain countries 
  • the potential for misuse, abuse, and fatal outcomes of oxycodone overdose requires lower therapeutic dosages and strict regulations

The potential for addiction and the negative effects of opioids have generated interest in non-opioid options to treat pain. Non-pharmacological therapies and the creation of new drug classes are examples of non-opioid options. Businesses that prioritise non-opioid pain treatment research and development might take a commanding position in the rapidly changing healthcare market.

Key Takeaways:

  • The oxycodone industry in the United Kingdom is anticipated to rise, exhibiting a CAGR of 5.5% through 2033
  • The United States held a 91.3% share of the global oxycodone industry in 2022
  • With a CAGR of 4.1% over the forecast period, India is predicted to develop rapidly in the oxycodone industry
  • In 2022, Japan had a 23.7% share of the oxycodone industry globally
  • The oxycodone industry in China is expected to increase, registering a CAGR of 5.6% over the forecast period
  • The pain management segment emerged as the leading power in the oxycodone industry, securing a 78.68% share of the global market
  • With a significant market share of 70.31%, the long acting oxycodone segment emerged as the dominant force in the oxycodone industry
  • The oxycodone industry was predominantly led by the retail pharmacies segment, capturing a 75.8% global share of the global market

Competitive Landscape in the Oxycodone Market:

Key players are implementing diverse strategies to uphold their market positions and expand their presence on a global scale. Following are a few of these strategies:

  • Developing oxycodone formulations that are difficult to misuse
  • Investing in improving efficacy and safety
  • Conducting rigorous clinical trials and generating robust scientific evidence to support the effectiveness
  • Continuously enhancing oxycodone formulations based on advancements
  • Strong campaigns to increase brand awareness
  • Working with healthcare providers and institutions
  • Ensuring adherence to quality and safety regulations
  • Targeting regions with high demand
  • Offering complementary medications and alternative routes

Recent Developments by Key Players in the Oxycodone Market:

Daiichi Sankyo Company, also known as Daiichi Sankyo, introduced a new generic version of oxycodone hydrochloride hydrate injection to treat cancer pain in June 2019. This unique formulation is called Oxycodone Injections 10 mg and 50 mg "Daiichi Sankyo." The introduction of this new formulation took place in Japan.

Daiichi Sankyo and Inspirion Delivery Sciences LLC announced their collaboration in May 2017. Daiichi Sankyo took the lead in commercializing RoxyBond™ (oxycodone hydrochloride) immediate-release tablets in the United States. These tablets received FDA approval and are designed for oral use (CII). Inspirion provided an additional salesforce as part of their co-promotion rights under the License Agreement. 

Leading Oxycodone Manufacturers as Profiled by FMI include:

  • Teva Pharmaceutical Industries Ltd.
  • Purdue Pharma L.P
  • Daiichi Sankyo
  • Acorda Therapeutics
  • Teikoku Pharma USA, Inc.
  • Mylan N.V
  • Endo Pharmaceuticals Inc.
  • Janssen Pharmaceuticals, Inc.

Key Segments Covered in Oxycodone Market Study:

By Oxycodone Type:

  • Long-acting oxycodone
  • Short-acting oxycodone

By Application:

  • Pain Management
  • De-addiction

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more